Global Sperm Bank Market Size

Sperm Bank Market Analysis

The Sperm Bank market is expected to record a CAGR of 3.3% over the forecast period (2022 - 2027).

The outbreak of COVID-19 showed an impact on the sperm bank market. COVID-19 not only affected the sperm bank market but the entire healthcare industry. It has disrupted the supply chain, leaving a financial burden on many companies. Due to this pandemic, there were nationwide lockdowns in almost every country which restricted people to come to sperm banks, hospitals, etc for sperm donation or collection due to safety issues. For instance, according to an article published by Springer, in January 2022, titled "Safety issues in semen banks during the COVID-19 pandemic: data from a European survey", it has been observed that the majority of the centers didn't adopt any especially extreme safety precautions to reduce the possibility of viral contamination or transmission. Additionally, as per the same source, in the case of positive nasopharyngeal swab (NPS) patients, only 4/22 laboratories stored the sample in a dedicated tank. Also, different countries have different rules for semen collection and storage. For instance, Italian gamete cryopreservation regulation has established that it is necessary to have dedicated cryogenic containers for each of the different screened pathologies to avoid virus contamination. Thus, the lack of safety during the initial time of the pandemic has negatively impacted the market growth. However, releasing COVID-19 restriction and several measures taken by the sperm banks and centers to avoid contamination is expected to drive the market growth over the forecast period.

Certain factors that are propelling the market growth are growing acceptance of the LGBT community, increasing prevalence of poor fertility, and advancement in cryopreservation. For instance, according to an article published by StatPearls, in July 2022, titled "Male Infertility", it has been found that infertility affects 15% of all couples in the United States and at least 180 million worldwide. In addition, the estimated male infertility rate is 9% in Australia and 8% to 12% in Eastern Europe. Thus, the high prevalence of infertility among men population across the globe is expected to increase the demand for another invitro process by using other human semen is expected to increase the market growth over the forecast period.

Also, according to an article published by StatPearls, in July 2022, titled "Male Infertility", a single-blinded study conducted in 2020, showed a proprietary daily antioxidant blend of coenzyme Q10 (30 mg), zinc (8 mg), vitamins C (100 mg), and E (12 mg), folic acid (400 micrograms), and selenium (200 mcg every other day) were taken for three months by 50 idiopathic infertile men with abnormal semen analyses (oligozoospermia and asthenozoospermia), resulted in statistically significant improvements in sperm count, concentration, motility, morphology as well as better semen volume and pH.

In addition, the rising prevalence of obesity is also a risk factor causing low sperm count in men and infertility or low chances of getting pregnant in females. For instance, according to 2022 statistics published by World Obesity Federation, it has been observed that 31.5% of men and 40.2% of women are living with obesity in Mexico in 2020. Similarly, according to statistics published by Code Blue.org, in November 2021, it has been observed that the prevalence of overweight and obesity in the Malaysian adult population increased to 54.2% in 2020 as compared to 50.1% in 2019.

Furthermore, the rising advancements in semen cryopreservation to preserve sperm cells are also contributing to the growth of the studied market. For instance, in January 2021, a report published on serum-free cryopreservation by Merck, ThermoFisher, and Zenoaq stated that using the cryopreservation technique the sperm can be preserved without blood products which reduces the risk of cross-species virus infections.

However, the lack of awareness among people and the low availability of sperm banks are likely to restrain the market growth over the forecast period.